Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,001.00p on 30-06-2026 at 11:20:53
Change 21.50p 1.09%
Buy 2,001.00p
Sell 2,000.00p
Last Trade: Sell 600.00 at 2,000.4659p
Day's Volume: 3,192,505
Last Close: 1,979.50p
Open: 1,999.50p
ISIN: GB00BN7SWP63
Day's Range 1,984.50p - 2,006.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £80.17b
VWAP: 1,996.61636p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 600 2,000.4659p Ordinary
12:20:52 - 30-Jun-26
Unknown* 0 2,001.00p SI Trade
12:20:01 - 30-Jun-26
Sell* 2 2,000.00p SI Trade
12:20:01 - 30-Jun-26
Unknown* 0 2,000.00p SI Trade
12:20:01 - 30-Jun-26
Unknown* 0 2,000.00p OTC Trade
12:19:51 - 30-Jun-26
Unknown* 0 2,000.00p OTC Trade
12:19:51 - 30-Jun-26
Unknown* 0 2,000.00p SI Trade
12:19:23 - 30-Jun-26
Unknown* 0 2,001.00p SI Trade
12:19:23 - 30-Jun-26
Unknown* 0 2,001.00p SI Trade
12:19:23 - 30-Jun-26
Unknown* 0 2,000.00p SI Trade
12:19:07 - 30-Jun-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Jun 2026 (Mon) 1,995.00 1,996.50 1,969.00 1,979.50 9,717,943
26th Jun 2026 (Fri) 1,972.50 1,995.50 1,945.50 1,983.00 13,837,274
25th Jun 2026 (Thu) 1,949.00 1,991.00 1,926.50 1,983.50 8,999,065
24th Jun 2026 (Wed) 1,967.00 1,984.00 1,950.00 1,950.00 5,923,852
23rd Jun 2026 (Tue) 1,915.00 1,971.00 1,911.00 1,957.50 8,305,282
22nd Jun 2026 (Mon) 1,925.00 1,931.50 1,912.00 1,924.50 3,565,700
19th Jun 2026 (Fri) 1,926.00 1,943.00 1,917.00 1,925.50 15,135,955
18th Jun 2026 (Thu) 1,976.00 1,978.50 1,906.00 1,923.00 7,565,324
17th Jun 2026 (Wed) 1,948.50 1,974.00 1,935.50 1,972.50 4,713,165
16th Jun 2026 (Tue) 1,955.50 1,968.00 1,940.50 1,950.00 6,759,168
15th Jun 2026 (Mon) 1,984.00 1,988.50 1,953.50 1,958.00 7,052,610
12th Jun 2026 (Fri) 1,963.50 2,011.00 1,960.00 1,984.00 5,538,575
11th Jun 2026 (Thu) 1,914.00 1,973.00 1,910.50 1,962.50 7,722,952
10th Jun 2026 (Wed) 1,915.50 1,929.00 1,890.50 1,921.50 6,411,067
9th Jun 2026 (Tue) 1,888.00 1,912.00 1,839.00 1,903.50 9,721,895
8th Jun 2026 (Mon) 1,936.50 1,942.50 1,904.50 1,913.00 4,169,869
5th Jun 2026 (Fri) 1,915.50 1,940.00 1,908.00 1,938.00 6,350,731
4th Jun 2026 (Thu) 1,859.50 1,904.00 1,859.00 1,902.00 12,974,263
3rd Jun 2026 (Wed) 1,817.50 1,856.50 1,813.00 1,851.50 8,183,347
2nd Jun 2026 (Tue) 1,840.00 1,842.00 1,805.00 1,820.50 6,580,750
1st Jun 2026 (Mon) 1,866.00 1,882.00 1,832.50 1,842.50 4,511,279
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
29th Jun 2026 3:00 pm RNS Transaction in Own Shares
29th Jun 2026 3:00 pm RNS Holding(s) in Company
26th Jun 2026 3:00 pm RNS Holding(s) in Company
24th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
24th Jun 2026 2:52 pm RNS GSK announces tender offer to acquire Nuvalent
23rd Jun 2026 3:30 pm RNS Director/PDMR Shareholding
22nd Jun 2026 3:00 pm RNS Transaction in Own Shares
17th Jun 2026 4:06 pm RNS cUTI oral antibiotic Tebipenem approved by US FDA
15th Jun 2026 3:00 pm RNS Transaction in Own Shares
12th Jun 2026 7:00 am RNS Momelotinib orphan drug designations for VEXAS
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: UBS, RBC and Citi cut easyJet; UBS lowers Mondi

30th Jun 2026 09:21

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: RBC ups Central Asia Metals to 'sector perform'

29th Jun 2026 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

GSK launches tender offer for USD10.6 billion purchase of Nuvalent

24th Jun 2026 15:45

(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug developer Nuvalent Inc for USD10.6 billion. Read More

IN BRIEF: GSK executives, including non-exec chair, buy shares

23rd Jun 2026 20:20

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. Director Vishal Sikka buys 1,266 ADS for USD50.69 each, for total USD64,175 on Monday, and Director Charles Bancroft buys 1,855 ADS for USD50.69 each, total USD94,031, also on Monday Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,602.20
Change117.98

Login to your account

Forgot Password?

Not Registered